12-113927218-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016196.4(RBM19):c.2080G>A(p.Glu694Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000289 in 1,559,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016196.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RBM19 | NM_016196.4 | c.2080G>A | p.Glu694Lys | missense_variant | 17/24 | ENST00000261741.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RBM19 | ENST00000261741.10 | c.2080G>A | p.Glu694Lys | missense_variant | 17/24 | 1 | NM_016196.4 | P1 | |
RBM19 | ENST00000392561.7 | c.2080G>A | p.Glu694Lys | missense_variant | 17/25 | 1 | P1 | ||
RBM19 | ENST00000545145.6 | c.2080G>A | p.Glu694Lys | missense_variant | 17/25 | 2 | P1 | ||
RBM19 | ENST00000552386.1 | n.214G>A | non_coding_transcript_exon_variant | 1/5 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.0000394 AC: 6AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000734 AC: 12AN: 163584Hom.: 0 AF XY: 0.0000580 AC XY: 5AN XY: 86208
GnomAD4 exome AF: 0.0000277 AC: 39AN: 1406990Hom.: 0 Cov.: 31 AF XY: 0.0000317 AC XY: 22AN XY: 694974
GnomAD4 genome ? AF: 0.0000394 AC: 6AN: 152298Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | The c.2080G>A (p.E694K) alteration is located in exon 17 (coding exon 17) of the RBM19 gene. This alteration results from a G to A substitution at nucleotide position 2080, causing the glutamic acid (E) at amino acid position 694 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at